Lymphoma, Non-Hodgkin's, Adult
5 clinical trials · Condition
◉ Watch Lymphoma, Non-Hodgkin's, Adult
| Record | Firm | Date |
|---|---|---|
| Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy (NCT06510361) | Beth Israel Deaconess Medical Center | 2024-11-20 |
| T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) (NCT06343311) | Estrella Biopharma, Inc. | 2024-06-01 |
| Study of SP-3164 in Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT05979857) | Salarius Pharmaceuticals, LLC | 2024-03-15 |
| PET Adapted Treatment of Patients With Limited Stage DLBCL and no Risk Factors (NCT05078840) | Grupo Argentino de Tratamiento de la Leucemia Aguda | 2021-06-01 |
| Safety, Tolerability, PK/PD of FE 203799 in Adults With Lymphomas (NCT03417765) | GlyPharma Therapeutics | 2018-09-01 |
Track Lymphoma, Non-Hodgkin's, Adult automatically
Every clearance here is in the API, with alerts when new ones post.